Patient & Survivor Care
From the Journals
Breast reconstruction post mastectomy: What matters most to women?
“This study provides information on how women value different aspects of their care when making decisions for breast reconstruction.”
Conference Coverage
Head, neck cancer radiotherapy regimen saves time when resources limited
A randomized controlled trial conducted in low- to middle-income countries showed that 11.5 days could be safely shaved off a conventional...
From the Journals
Does surgery improve survival in metastatic breast cancer?
“The analysis revealed no overall survival benefit for patients who underwent surgical excision of their primary breast tumor.”
Conference Coverage
‘Reassuring’ follow-up validates radiation strategy for early breast cancer
At 10 years, partial-breast/reduced-dose therapy are still noninferior to whole-breast approach.
Conference Coverage
Higher RT doses can boost lifespan, reduce risk of death in LS-SCLC patients
“We need more technical details to understand how to deliver this regimen in clinical practice, and it may not be applicable for all patients.”
Conference Coverage
CT simulation not needed in palliative radiotherapy planning
“Diagnostic CT-based radiation planning substantially reduces time in the [treatment] center without a detriment in plan deliverability or quality...
Conference Coverage
Reducing cognitive impairment from SCLC brain metastases
Stereotactic radiosurgery was better at preventing loss of verbal recall function at 3 months than whole-brain radiation therapy, the current...
Conference Coverage
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...
Conference Coverage
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’
The use of the higher-dose approach, known as hypofractionation, “resulted in fewer treatment breaks and less financial toxicity.”
Conference Coverage
SABR could defer systemic therapy in oligoprogressive breast cancer
“We found surprisingly that SABR delayed a change in therapy by 10 months, which is great for patients.”
Conference Coverage
Salvage option to replace transplant in r/r Hodgkin lymphoma?
“The findings suggest that children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma can be salvaged with low-...